138 related articles for article (PubMed ID: 24584175)
41. Cholesterol-independent effects of atorvastatin prevent cardiovascular morbidity and mortality in a mouse model of atherosclerotic plaque rupture.
Roth L; Rombouts M; Schrijvers DM; Martinet W; De Meyer GR
Vascul Pharmacol; 2016 May; 80():50-8. PubMed ID: 26826559
[TBL] [Abstract][Full Text] [Related]
42. The effect of atorvastatin on erythrocyte membranes and serum lipids in patients with type-2 hypercholesterolemia.
Koter M; Broncel M; Chojnowska-Jezierska J; Klikczynska K; Franiak I
Eur J Clin Pharmacol; 2002 Nov; 58(8):501-6. PubMed ID: 12451426
[TBL] [Abstract][Full Text] [Related]
43. Probucol inhibits MMP-9 expression through regulating miR-497 in HUVECs and apoE knockout mice.
Wang YY; Li H; Wang XH; Yuan M; Li GP
Thromb Res; 2016 Apr; 140():51-58. PubMed ID: 26897284
[TBL] [Abstract][Full Text] [Related]
44. [Effects of probucol, aspirin and atorvastatin combination therapy upon atherosclerosis].
Meng XP; Wang SX; Zhang JC; Li ZX; Geng L; Yin CY
Zhonghua Yi Xue Za Zhi; 2009 Jul; 89(28):1986-8. PubMed ID: 19950575
[TBL] [Abstract][Full Text] [Related]
45. Probucol and cilostazol exert a combinatorial anti-atherogenic effect in cholesterol-fed rabbits.
Chen Y; Zhao S; Huang B; Wang Y; Li Y; Waqar AB; Liu R; Bai L; Fan J; Liu E
Thromb Res; 2013 Nov; 132(5):565-71. PubMed ID: 24090606
[TBL] [Abstract][Full Text] [Related]
46. Mesenchymal Stem Cells Stabilize Atherosclerotic Vulnerable Plaque by Anti-Inflammatory Properties.
Wang SS; Hu SW; Zhang QH; Xia AX; Jiang ZX; Chen XM
PLoS One; 2015; 10(8):e0136026. PubMed ID: 26288013
[TBL] [Abstract][Full Text] [Related]
47. The Arginine/ADMA Ratio Is Related to the Prevention of Atherosclerotic Plaques in Hypercholesterolemic Rabbits When Giving a Combined Therapy with Atorvastatine and Arginine.
Brinkmann SJ; Wörner EA; Buijs N; Richir M; Cynober L; van Leeuwen PA; Couderc R
Int J Mol Sci; 2015 May; 16(6):12230-42. PubMed ID: 26035753
[TBL] [Abstract][Full Text] [Related]
48. Treatment with amlodipine and atorvastatin has additive effect on blood and plaque inflammation in hypertensive patients with carotid atherosclerosis.
Martín-Ventura JL; Muñoz-Garcia B; Blanco-Colio LM; Martín-Conejero A; Madrigal-Matute J; Vega M; Ortega L; Serrano J; Egido J
Kidney Int Suppl; 2008 Dec; (111):S71-4. PubMed ID: 19034332
[TBL] [Abstract][Full Text] [Related]
49. Morphological features of coronary plaques in WHHLMI rabbits (Oryctolagus cuniculus), an animal model for familial hypercholesterolemia.
Yamada S; Koike T; Nakagawa T; Kuniyoshi N; Ying Y; Itabe H; Yamashita A; Asada Y; Shiomi M
Exp Anim; 2017 May; 66(2):145-157. PubMed ID: 28025424
[TBL] [Abstract][Full Text] [Related]
50. Atorvastatin inhibits CXCR7 induction to reduce macrophage migration.
Ma W; Liu Y; Wang C; Zhang L; Crocker L; Shen J
Biochem Pharmacol; 2014 May; 89(1):99-108. PubMed ID: 24582769
[TBL] [Abstract][Full Text] [Related]
51. Combined effect of atorvastatin and probucol on plasma cystatin C levels and severity of coronary lesion in patients with borderline coronary lesion.
Ge CJ; Lü SZ; Feng LX; Huo Y; Song XT; Chen X; Meng K; Yuan F
Chin Med J (Engl); 2012 Jul; 125(14):2472-6. PubMed ID: 22882924
[TBL] [Abstract][Full Text] [Related]
52. Statin therapy prevents expansive remodeling in venous bypass grafts.
Qiang B; Toma J; Fujii H; Osherov AB; Nili N; Sparkes JD; Fefer P; Samuel M; Butany J; Leong-Poi H; Strauss BH
Atherosclerosis; 2012 Jul; 223(1):106-13. PubMed ID: 22503825
[TBL] [Abstract][Full Text] [Related]
53. Effect of low dose atorvastatin versus diet-induced cholesterol lowering on atherosclerotic lesion progression and inflammation in apolipoprotein E*3-Leiden transgenic mice.
Verschuren L; Kleemann R; Offerman EH; Szalai AJ; Emeis SJ; Princen HM; Kooistra T
Arterioscler Thromb Vasc Biol; 2005 Jan; 25(1):161-7. PubMed ID: 15514207
[TBL] [Abstract][Full Text] [Related]
54. Atorvastatin attenuates atherosclerotic plaque destabilization by inhibiting endoplasmic reticulum stress in hyperhomocysteinemic mice.
Jia F; Wu C; Chen Z; Lu G; Sun J
Mol Med Rep; 2016 Apr; 13(4):3574-80. PubMed ID: 26956896
[TBL] [Abstract][Full Text] [Related]
55. [Effects of Tongxinluo and Simvastatin on the stabilization of vulnerable atherosclerotic plaques of aorta in aortic atherosclerosis and molecular mechanism thereof: a comparative study with rabbits].
Li Z; Yang YJ; Qin XW; Ruan YM; Chen X; Meng L; Zhang HD
Zhonghua Yi Xue Za Zhi; 2006 Nov; 86(44):3146-50. PubMed ID: 17313769
[TBL] [Abstract][Full Text] [Related]
56. Effects of atorvastatin on C-reactive protein secretions by adipocytes in hypercholesterolemic rabbits.
Zhang D; Che D; Zhao S; Sun Y
J Cardiovasc Pharmacol; 2007 Sep; 50(3):281-5. PubMed ID: 17878756
[TBL] [Abstract][Full Text] [Related]
57. Atorvastatin improves plaque stability in ApoE-knockout mice by regulating chemokines and chemokine receptors.
Nie P; Li D; Hu L; Jin S; Yu Y; Cai Z; Shao Q; Shen J; Yi J; Xiao H; Shen L; He B
PLoS One; 2014; 9(5):e97009. PubMed ID: 24816562
[TBL] [Abstract][Full Text] [Related]
58. Mechanism of the inhibitory effect of atorvastatin on leptin expression induced by angiotensin II in cultured human coronary artery smooth muscle cells.
Shyu KG; Chen SC; Wang BW; Cheng WP; Hung HF
Clin Sci (Lond); 2012 Jan; 122(1):33-42. PubMed ID: 21806545
[TBL] [Abstract][Full Text] [Related]
59. Probucol and atorvastatin decrease urinary 8-hydroxy-2'-deoxyguanosine in patients with diabetes and hypercholesterolemia.
Endo K; Miyashita Y; Sasaki H; Ebisuno M; Ohira M; Saiki A; Koide N; Oyama T; Takeyoshi M; Shirai K
J Atheroscler Thromb; 2006 Feb; 13(1):68-75. PubMed ID: 16505594
[TBL] [Abstract][Full Text] [Related]
60. Long-term hemostatic effects of cholesterol-lowering therapy with atorvastatin.
Trifiletti A; Lasco A; Scamardi R; Pizzoleo MA; Gaudio A; La Rocca R; Morini E; Frisina N
Pathophysiol Haemost Thromb; 2003; 33(2):84-7. PubMed ID: 14624049
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]